<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The gene for erythrocyte <z:chebi fb="0" ids="16856">glutathione</z:chebi> reductase (E-GR) activity has been assigned to chromosome #8 </plain></SENT>
<SENT sid="1" pm="."><plain>In the present series, we examined the E-GR activity in 14 cases with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (CMS, <z:e sem="disease" ids="C0026986,C0033027" disease_type="Neoplastic Process" abbrv="">preleukemia</z:e>), atypical <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), or <z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), with and without acquired <z:mp ids='MP_0004027'>trisomy</z:mp> #8 </plain></SENT>
<SENT sid="2" pm="."><plain>No difference in the incidence of high levels of this enzyme was found between two groups, i.e., those with and without <z:mp ids='MP_0004027'>trisomy</z:mp> #8 suggesting the existence of a complex regulatory system in addition to chromosome #8 </plain></SENT>
</text></document>